Cidara Therapeutics Inc (NASDAQ:CDTX)
| 1.31 Delayed Data As of Jun 02 |  -0.01 / -0.76%Today’s Change | 0.40 Today|||52-Week Range 2.10 | +73.21% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -32.2M | -48.2M | -55.7M | -59.0M | |
| Depreciation | 461.0K | 732.0K | 667.0K | 523.0K | ||
| Total Other Cash Flow | 3.1M | 4.2M | 5.7M | 2.2M | ||
| Funds From Operations | -28.7M | -43.3M | -49.3M | -56.3M | ||
| Funds From/For Other Operating Expenses | -2.7M | -3.5M | 579.0K | 399.0K | ||
| Net Cash Flow - Operating Activities | -26.0M | -39.8M | -49.9M | -56.7M | ||
| Investing | Increase In Investments | -54.9M | -69.6M | -19.5M | -14.5M | |
| Decrease In Investments | 10.0M | 95.5M | 24.3M | 29.0M | ||
| Capital Expenditures | -1.2M | -401.0K | -306.0K | -177.0K | ||
| Net Cash Flow Investing | -46.1M | 25.5M | 4.5M | 14.3M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 9.9M | 0.00 | 0.00 | ||
| Long Term Debt Reduction | 0.00 | -- | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | 111.8M | 27.1M | 21.0M | 56.2M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | -79.0K | 0.00 | ||
| Common Dividends | 0.00 | 0.00 | -- | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | -- | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 111.8M | 37.1M | 20.9M | 56.2M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 39.8M | 22.8M | -24.6M | 13.7M | ||
